AAAAAA
Results: 1-25/52
Authors:
OMENN GS
Citation: Gs. Omenn, HEALTH-STATUS AND ITS DETERMINANTS IN URBAN POPULATIONS, JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 75(2), 1998, pp. 219-227
Authors:
GOODMAN GE
VALANIS B
MEYSKENS FL
WILLIAMS JH
METCH BJ
THORNQUIST MD
OMENN GS
Citation: Ge. Goodman et al., STRATEGIES FOR RECRUITMENT TO A POPULATION-BASED LUNG-CANCER PREVENTION TRIAL - THE CARET EXPERIENCE WITH HEAVY SMOKERS, Cancer epidemiology, biomarkers & prevention, 7(5), 1998, pp. 405-412
Authors:
OMENN GS
Citation: Gs. Omenn, INTERPRETATIONS OF THE LINXIAN VITAMIN SUPPLEMENT CHEMOPREVENTION TRIALS, Epidemiology, 9(1), 1998, pp. 1-4
Authors:
OMENN GS
Citation: Gs. Omenn, HOT PAPERS - CANCER PREVENTION - EFFECTS OF A COMBINATION OF BETA-CAROTENE AND VITAMIN-A ON LUNG AND CARDIOVASCULAR-DISEASE BY OMENN,G.S., GOODMAN,G.E., THORNQUIST,M.D., BALMES,J., CULLEN,M.R., GLASS,A., KEOGH,J.P., MEYSKENS,F.L. JR., VALANIS,B., WILLIAMS,J.H. JR., BARNHART,SCOTT, HAMMAR,SAMUEL - COMMENTS, The Scientist, 12(10), 1998, pp. 11-11
Authors:
OMENN GS
Citation: Gs. Omenn, CHEMOPREVENTION OF LUNG-CANCER - THE RISE AND DEMISE OF BETA-CAROTENE, Annual review of public health, 19, 1998, pp. 73-99
Authors:
OMENN GS
BERESFORD SAA
MOTULSKY AG
Citation: Gs. Omenn et al., PREVENTING CORONARY HEART-DISEASE - VITAMIN-B AND HOMOCYSTEINE, Circulation, 97(5), 1998, pp. 421-424
Authors:
OMENN GS
THORNQUIST MD
Citation: Gs. Omenn et Md. Thornquist, BETA-CAROTENE AND THE RISK OF LUNG-CANCER - RESPONSES, Journal of the National Cancer Institute, 89(6), 1997, pp. 457-458
Authors:
OMENN GS
Citation: Gs. Omenn, RISK-FACTORS FOR LUNG-CANCER AND FOR INTERVENTION EFFECTS IN CARET, THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL - RESPONSE, Journal of the National Cancer Institute, 89(4), 1997, pp. 325-326
Authors:
OMENN GS
Citation: Gs. Omenn, RISK-FACTORS FOR LUNG-CANCER AND FOR INTERVENTION EFFECTS IN CARET, THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL - RESPONSE, Journal of the National Cancer Institute, 89(22), 1997, pp. 1723-1723
Authors:
CHARNLEY G
OMENN GS
Citation: G. Charnley et Gs. Omenn, WITH A SUMMARY OF THE FINDINGS AND RECOMMENDATIONS OF THE COMMISSION ON RISK ASSESSMENT AND RISK MANAGEMENT, Human and ecological risk assessment, 3(5), 1997, pp. 701-711
Authors:
OMENN GS
Citation: Gs. Omenn, OUR CHILDRENS TOXIC LEGACY - HOW SCIENCE AND LAW FAIL TO PROTECT US FROM PESTICIDES - WARGO,J, Issues in science and technology, 14(1), 1997, pp. 93-95
Authors:
OHANIAN EV
MOORE JA
FOWLE JR
OMENN GS
LEWIS SC
GRAY GM
NORTH DW
Citation: Ev. Ohanian et al., RISK CHARACTERIZATION - A BRIDGE TO INFORMED DECISION-MAKING, Fundamental and applied toxicology, 39(2), 1997, pp. 81-88
Authors:
BRODKIN CA
MCCULLOUGH J
STOVER B
BALMES J
HAMMAR S
OMENN GS
CHECKOWAY H
BARNHART S
Citation: Ca. Brodkin et al., LOBE OF ORIGIN AND HISTOLOGIC TYPE OF LUNG-CANCER ASSOCIATED WITH ASBESTOS EXPOSURE IN THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET), American journal of industrial medicine, 32(6), 1997, pp. 582-591
Authors:
DEYO RA
PSATY BM
SIMON G
WAGNER EH
OMENN GS
Citation: Ra. Deyo et al., THE MESSENGER UNDER ATTACK - INTIMIDATION OF RESEARCHERS BY SPECIAL-INTEREST GROUPS, The New England journal of medicine, 336(16), 1997, pp. 1176-1180
Authors:
OMENN GS
GOODMAN GE
THORNQUIST MD
BALMES J
CULLEN MR
GLASS A
KEOGH JP
MEYSKENS FL
VALANIS B
WILLIAMS JH
BARNHART S
CHERNIACK MG
BRODKIN CA
HAMMAR S
Citation: Gs. Omenn et al., RISK-FACTORS FOR LUNG-CANCER AND FOR INTERVENTION EFFECTS IN CARET, THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL, Journal of the National Cancer Institute, 88(21), 1996, pp. 1550-1559
Authors:
GOODMAN GE
THORNQUIST M
KESTIN M
METCH B
ANDERSON G
OMENN GS
Citation: Ge. Goodman et al., THE ASSOCIATION BETWEEN PARTICIPANT CHARACTERISTICS AND SERUM CONCENTRATIONS OF BETA-CAROTENE, RETINOL, RETINYL PALMITATE, AND ALPHA-TOCOPHEROL AMONG PARTICIPANTS IN THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET) FOR PREVENTION OF LUNG-CANCER, Cancer epidemiology, biomarkers & prevention, 5(10), 1996, pp. 815-821
Authors:
OMENN GS
Citation: Gs. Omenn, MAKING USE OF CANCER RISK ASSESSMENT, Issues in science and technology, 12(4), 1996, pp. 29-32
Authors:
GOODMAN GE
OMENN GS
THORNQUIST MD
Citation: Ge. Goodman et al., CARET - THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL FOR THE CHEMOPREVENTION OF LUNG-CANCER IN HIGH-RISK POPULATIONS, Journal of clinical oncology, 14(5), 1996, pp. 2023-2023
Authors:
KELLOFF GJ
CROWELL JA
HAWK ET
STEELE VE
LUBET RA
BOONE CW
COVEY JM
DOODY LA
OMENN GS
GREENWALD P
HONG WK
PARKINSON DR
BAGHERI D
BAXTER GT
BLUNDEN M
DOELTZ MK
EISENHAUER KM
JOHNSON K
KNAPP GG
LONGFELLOW DG
MALONE WF
NAYFIELD SG
SEIFRIED HE
SWALL LM
SIGMAN CC
Citation: Gj. Kelloff et al., STRATEGY AND PLANNING FOR CHEMOPREVENTIVE DRUG DEVELOPMENT - CLINICALDEVELOPMENT PLANS-II, Journal of cellular biochemistry, 1996, pp. 54-71
Authors:
KELLOFF GJ
CROWELL JA
HAWK ET
STEELE VE
LUBET RA
BOONE CW
COVEY JM
DOODY LA
OMENN GS
GREENWALD P
HONG WK
PARKINSON DR
BAGHERI D
BAXTER GT
BLUNDEN M
DOELTZ MK
EISENHAUER KM
JOHNSON K
KNAPP GG
LONGFELLOW DG
MALONE WF
NAYFIELD SG
SEIFRIED HE
SWALL LM
SIGMAN CC
Citation: Gj. Kelloff et al., CLINICAL DEVELOPMENT PLANS FOR CANCER CHEMOPREVENTIVE AGENTS, Journal of cellular biochemistry, 1996, pp. 72-321
Authors:
OMENN GS
Citation: Gs. Omenn, RISK ASSESSMENT FOR BUTADIENE - INTRODUCTORY AND SUMMARY COMMENTS, Toxicology, 113(1-3), 1996, pp. 5-11
Authors:
BOIKO PE
MORRILL RL
FLYNN J
FAUSTMAN EM
VANBELLE G
OMENN GS
Citation: Pe. Boiko et al., WHO HOLDS THE STAKES - A CASE-STUDY OF STAKEHOLDER IDENTIFICATION AT 2 NUCLEAR-WEAPONS PRODUCTION SITES, Risk analysis, 16(2), 1996, pp. 237-249
Authors:
OMENN GS
Citation: Gs. Omenn, UNTITLED, Annual review of public health, 17, 1996, pp. 5-7
Authors:
GORDON RL
BAKER EL
ROPER WL
OMENN GS
Citation: Rl. Gordon et al., PREVENTION AND THE REFORMING US HEALTH-CARE SYSTEM - CHANGING ROLES AND RESPONSIBILITIES FOR PUBLIC-HEALTH, Annual review of public health, 17, 1996, pp. 489-509
Authors:
BERESFORD SAA
MOTULSKY AG
OMENN GS
BOUSHEY CJ
Citation: Saa. Beresford et al., FOLIC-ACID FORTIFICATION OF FOOD - REPLY, JAMA, the journal of the American Medical Association, 275(9), 1996, pp. 682-683